News

Filter

Current filters:

Capoten

1 to 9 of 129 results

Domestic vs JV drug prices in China differ

20-08-2007

In China, the prices at which of pharmaceuticals produced by domestic firms and overseas joint ventures…

AspirinBayerBayerCapotenCaptoprilDipyridamoleGlaxoSmithKlineGSKHismanalJohnson & JohnsonOmeprazolePersantinePrilosec

Novartis gets broader FDA indication, for heart failure, on Diovan

15-08-2005

The US Food and Drug Administration has approved Swiss pharmaceutical major Novartis' Diovan (valsartan),…

CapotenCaptoprilDiovanNovartisvalsartan

Novartis' Diovan gets EU nod for heart attack

16-05-2005

Switzerland's number one drugmaker Novartis has obtained European Union approval for its high blood-pressure…

CapotenCaptoprilDiovanNovartisvalsartan

Novartis' Diovan gets UK OK for new use

01-11-2004

Novartis says that its angiotensin II receptor blocker Diovan (valsartan) has been licensed in the UK…

CapotenCaptoprilDiovanNovartisvalsartan

Novartis files for new use of Diovan

09-02-2004

Novartis has submitted regulatory applications to a range of authorities for a new indication for its…

CapotenCaptoprilDiovanNovartisvalsartan

Novartis' Diovan is as beneficial as captopril in heart attack patients

17-11-2003

Data were presented at the annual meeting of the American HeartAssociation, in Orlando, Florida, showing…

CapotenCaptoprilDiovanNovartisvalsartan

1 to 9 of 129 results

Back to top